Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Maria A. Nana"'
Autor:
Styliani Vakrou, Maria A. Nana, Ioannis A. Nanas, Emmeleia Nana-Leventaki, Michael Bonios, Chris Kapelios, John Nanas
Publikováno v:
Hellenic Journal of Cardiology, Vol 61, Iss 4, Pp 256-261 (2020)
Objective: Cardiosphere-derived cells (CDCs) have been shown to reduce infarct size after myocardial infarction (MI). In the present study we investigated the safety and efficacy of global intracoronary administration (GIA) of CDCs or CDC-conditioned
Externí odkaz:
https://doaj.org/article/81b6b3461e464148ad0507ba1b5f1c5f
Autor:
Michael J. Bonios, MD, Maria Anastasiou-Nana, MD, Despina N. Perrea, MD, Konstantinos Malliaras, MD
Publikováno v:
Hellenic Journal of Cardiology, Vol 58, Iss 2, Pp 135-142 (2017)
Background: Left ventricular reconstruction (LVR) has been shown to provide transient benefits to the LV structure and function of infarcted hearts; however, long-term results have been disappointing as LVR-induced benefits are typically not sustaine
Externí odkaz:
https://doaj.org/article/7ee573aaad54411583113a4c2b1af164
Publikováno v:
Artery Research, Vol 5, Iss 3 (2011)
Individuals infected with human immunodeficiency virus (HIV) frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. Extensive functional and structural arterial wall changes have been observed in these
Externí odkaz:
https://doaj.org/article/7ba02a936d264d00bd11c4c908979b6e
Autor:
Konstantinos Malliaras, Stella Vakrou, Chris J. Kapelios, Michalis Tsamatsoulis, Maria Anastasiou-Nana, Lambros Katsaros, Vasilis Sousonis, Stefania Sventzouri, Nicholas Michelinakis, Despoina Perrea
Publikováno v:
International Journal of Cardiology. 224:90-95
Background The Translocator Protein (TSPO) of the mitochondrial membrane has been recognized as a potential therapeutic target for mitigation of myocardial ischemia-reperfusion injury. Administration of 4-chlorodiazepam (4-CLD), a TSPO ligand, has be
Autor:
Anastasia Zoga, S.I. Bibli, Nicole Pouli, S. Vasileiou, Maria Anastasiou-Nana, D. Kremastinos, E. Iliodromitis, Panagiotis Efentakis, Ioanna Andreadou
Publikováno v:
European Journal of Pharmacology. 789:431-438
We tested the hypothesis that ranolazine (Ran) is cardioprotective in a model of ischemia /reperfusion and we elucidated the intracellular mechanism. Anesthetized rabbits were subjected to is chemia and reperfusion and were divided into 5 groups: 1)
Afterload-induced left ventricular diastolic dysfunction during myocardial ischaemia and reperfusion
Autor:
Lampros Katsaros, Iraklis Pozios, Konstantinos Malliaras, John Terrovitis, Apostolos Papalois, Nikolaos A. Diakos, Stefania Sventzouri, Styliani Vakrou, Michael J. Bonios, Maria Anastasiou-Nana, Nikolaos Michelinakis, Eleni Tseliou
Publikováno v:
Experimental Physiology. 100:288-301
New Findings What is the central question of this study? While the load dependence of the diastolic function is established for the normal heart, little is known about the response of the acutely ischaemic and reperfused myocardium to alterations in
Autor:
John Lekakis, Chrysoula Katseli, Ignatios Ikonomidis, Ioanna Andreadou, Stavros Tzortzis, George Pavlidis, Maria Anastasiou-Nana, Ioannis Paraskevaidis, Dimitrios Th. Kremastinos, Pelagia Katsimbri, John Parissis
Publikováno v:
Circulation: Cardiovascular Imaging. 7:619-628
Background— We investigated the effects of anakinra, an interleukin-1 receptor antagonist, on coronary and left ventricular function in coronary artery disease (CAD) patients with rheumatoid arthritis. Methods and Results— In a double-blind cross
Autor:
Ferenc Follath, Nikolaos P.E. Kadoglou, Giussepe Ambrosio, Ioanna Dimopoulou, Chiara Andreoli, Alexandre Mebazaa, Maria Anastasiou-Nana, Mitja Lainscak, Dimitrios Farmakis, Ignatios Ikonomidis, Efstathios K. Iliodromitis, Gerasimos Filippatos, John Parissis
Publikováno v:
Clinical Research in Cardiology. 103:733-741
ALARM-HF was a retrospective, observational registry that included 4,953 patients admitted for acute heart failure (AHF) in six European countries, Turkey, Mexico and Australia. Data about respiratory disorders and related medications were available
Autor:
John Lekakis, Loukianos S. Rallidis, Dimitrios Karatzas, Efstathios K. Iliodromitis, Nikolaos Dagres, Eftihia Simeonidou, Panagiotis Simitsis, Maria Anastasiou-Nana
Publikováno v:
Journal of Cardiovascular Medicine. 15:254-259
The use of currently available antiarrhythmic drugs for atrial fibrillation is limited by their moderate efficacy and the considerable proarrhythmic risk. Ranolazine, an antianginal agent, has been reported to possess antiarrhythmic properties, resul
Autor:
John Parissis, Nikolaos P.E. Kadoglou, Ioanna Dimopoulou, John A Papadakis, Panagiotis Psarogiannakopoulos, Gerasimos Filippatos, Maria Anastasiou-Nana, Christos Varounis, Kleante Dima, Ignatios Ikonomidis, Ioannis Paraskevaidis, Penelope Rafouli-Stergiou, Aikaterini Zerva
Publikováno v:
International Journal of Cardiology. 168:3609-3612
High-sensitivity troponin Τ (hs-TnΤ) allows the detection of very minor myocardial injury and has emerged as a novel prognostic marker in patients with cardiovascular disease. The aim of the present study was to determine the prognostic utility of